Concepedia

H A Mansaray

HA

Statistics

Publications

3

Citations

111

H-Index

3

Active since

2021

Affiliations

University of Sierra Leone(Current)

Janssen (Netherlands)

Janssen (Belgium)

Mwanza Intervention Trials Unit

National Institute for Medical Research

H A Mansaray is an author at University of Sierra Leone specializing in emerging infectious diseases, vaccine safety, and epidemiology.

Top concepts

Publications per year

2021–2023

3

Publications

3

Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in children in Sierra Leone: a randomised, double-blind, controlled trial

Muhammed O. Afolabi, David Ishola, Daniela Manno et al. · The Lancet Infectious Diseases · 2021 · 89 citations · Full text

, , +9

Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in infants: a phase 2, randomised, double-blind, active-controlled trial in Guinea and Sierra Leone

E Choi, Boris Lacarra, Muhammed O. Afolabi et al. · The Lancet Global Health · 2023 · 12 citations · Full text

Early life Bacillus Calmette-Guerin vaccination and incidence of type 1, type 2, and latent autoimmune diabetes in adulthood

Philippe Corsenac, Marie‐Élise Parent, H A Mansaray et al. · Diabetes & Metabolism · 2022 · 10 citations

1–3 of 3